Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization
Journal of Agricultural and Food Chemistry · 19.08.2026 · 74 (32) · 25252-25271
DOI: 10.1021/acs.jafc.6c04447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 10.08.2026. Verfasst von Wenshan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing210022, China. Hauptthemen laut MEDLINE: Ginsenosides, Microglia, Wnt Signaling Pathway, Parkinson Disease. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Microglial-mediated neuroinflammation is a core driver of brain disorders. Thus, modulating microglial activity is a critical therapeutic goal. In this study, we explored how Ginsenoside Rg1 (Rg1) protects against the inflammation seen in Parkinson’s disease (PD). Our experiments utilized MPTP-challenged mice and lipopolysaccharide (LPS)-stimulated BV2 cells. Our data show that Rg1 restores motor function and preserves dopaminergic neurons in the substantia nigra. Notably, Rg1 treatment reconfigures the neuroinflammatory milieu, characterized by the targeted suppression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and a reciprocal elevation of the anti-inflammatory marker (IL-10). This effect stems from a precise rebalancing of Wnt signaling. Rg1 activates the Wnt3a/β-catenin pathway while suppressing the Wnt5a/ROR2/JNK axis. Such regulation promotes the transition of microglia to a protective M2 phenotype. When we knocked down Wnt3a and ROR2 using siRNA, the benefits of Rg1 were largely lost. In short, Rg1 alleviates neuroinflammation by recalibrating Wnt signals, offering a potential strategy for PD intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing210022, China.
- Department of Orthopedics, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing210022, China.
ORCID-Profile: Yan Lu
Förderung
- National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Li, W., Yu, X., Zhang, Z., Zhang, J., Jin, Z., Jiang, Y., Zhu, X., Xu, C., Sun, X., & Lu, Y. (2026). Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization. Journal of Agricultural and Food Chemistry, 74(32), 25252-25271. https://doi.org/10.1021/acs.jafc.6c04447
Vancouver
Li W, Yu X, Zhang Z, Zhang J, Jin Z, Jiang Y, et al. Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization. Journal of Agricultural and Food Chemistry. 2026;74(32):25252-25271. doi:10.1021/acs.jafc.6c04447
BibTeX
@article{Li2026,
author = {Li, Wenshan and Yu, Xinlang and Zhang, Zhiying and Zhang, Jiakang and Jin, Zhihui and Jiang, Yanjie and Zhu, Xiaoyu and Xu, Chengcheng and Sun, Xin and Lu, Yan},
title = {Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
volume = {74},
number = {32},
pages = {25252--25271},
doi = {10.1021/acs.jafc.6c04447}
}
EUVIMED